Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1

Status

Recruiting 8Completed 5Unknown 3Terminated 3Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 2Lymphoma, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × Consolidation Chemotherapy × Clear all
NCT02927938 2022-04-21

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

Wake Forest University Health Sciences

Phase 3 Terminated
18 enrolled 25 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01246752 2021-10-29

AML

University Hospital Carl Gustav Carus

Phase 3 Terminated
143 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00906841 2018-04-27

Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma

French Innovative Leukemia Organisation

Phase 2 Terminated
75 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡